Today, Amgen and AstraZeneca announced positive top-line results from their Phase 3 WAYPOINT trial evaluating a treatment for adults affected by chronic rhinosinusitis with nasal polyps (#CRSwNP). ?? Press Release: https://amgen.ly/3YEbKeX
QuantumVital
2 天前
Wunderbar!
Phil Barrion
2 天前
Congratulations!
Congratulations!
Congrats!
President and CEO of Venebio Group, LLC. Data Driven Solutions. Epidemiology. Real World Evidence Strategy. REMS. Scientific Litigation Support.
16 小时前Fantastic news. Congratulations to both companies, and the teams involved in making this happen.